ABT Abbott Laboratories Earnings and EPS analysis

EPS in 2025 (TTM): $7.72

Last Report Period Date: Mar 31, 2025

As of May this year, based on Abbott Laboratories's most recent financial report, the company's trailing twelve months EPS is $7.72. Abbott Laboratories's earnings per share in 2024 was reported at $7.67, marking a rise from $3.28 in 2023. Abbott Laboratories's EPS for the quarterly period ending on Mar 31, 2025 came in at $0.76.

The yearly earnings per share during 2024 was $7.67, a rise of 133.8% compared to $3.28 recorded in 2023. The quarterly earnings per share for the period ending Mar 31, 2025, was $0.76, showing a 8.6% increase compared to the same quarter last year. The trailing twelve months EPS for ABT is $7.72 as of March 2025. Abbott Laboratories's full-year EPS for 2023 was $3.28, a 16.8% decline compared to the previous year.

In the past 12 months, Abbott Laboratories has recorded an earnings per share growth rate of 8.6% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 24.5% per year. In the last five years, the company had an average annual EPS growth of 29.9%. When assessed over a ten-year period, ABT's average EPS annual growth was 17.7%.